HIV-1 coreceptor usage, transmission, and disease progression
- PMID: 15043204
- DOI: 10.2174/1570162033485357
HIV-1 coreceptor usage, transmission, and disease progression
Abstract
HIV-1 coreceptor usage is believed to play a critical role in pathogenesis. To initiate infection, HIV-1 interacts with two cell surface receptors; CD4 is the primary receptor and the beta-chemokine receptors CCR5 and CXCR4 usually serve as secondary receptors. HIV-1 strains transmitted in vivo generally use CCR5. Viruses that use CCR5 (R5 viruses) appear to be associated with relatively stable infection. Years after chronic infection is established, CXCR4 utilizing strains emerge in approximately 50% of infected individuals. Viruses that use the coreceptor CXCR4 (X4 viruses) are associated with rapid CD4+ cell decline and disease progression. However, the mechanism by which X4 viruses are associated with accelerated disease progression has never been properly elucidated. For example, the association between X4 virus and acceleration of HIV-1 disease progression has been ascribed to the expanded spectrum of CXCR4+ precursor cells susceptible to infection by X4 strains. It has also been postulated that the decline of the host immune system associated with clinical AIDS may allow X4 viruses to evolve and replicate freely in late-stage infection. Discriminating between these and other alternatives is central to increasing our understanding of the fundamental pathogenic processes involved in HIV-1 infection. In this article, we critically review those studies published over the last few years that purport to examine the relationship between HIV-1 coreceptor usage, transmission, CD4+ T-cell depletion, and disease progression.
Similar articles
-
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.J Virol. 2020 Jun 1;94(12):e00193-20. doi: 10.1128/JVI.00193-20. Print 2020 Jun 1. J Virol. 2020. PMID: 32295903 Free PMC article.
-
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14. Infect Genet Evol. 2010. PMID: 19446658
-
V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.J Virol. 2005 Oct;79(19):12296-303. doi: 10.1128/JVI.79.19.12296-12303.2005. J Virol. 2005. PMID: 16160156 Free PMC article.
-
The epidemiology of HIV coreceptor tropism.Eur J Med Res. 2007 Oct 15;12(9):385-90. Eur J Med Res. 2007. PMID: 17933718 Review.
-
Relationships Between HIV-Mediated Chemokine Coreceptor Signaling, Cofilin Hyperactivation, Viral Tropism Switch and HIV-Mediated CD4 Depletion.Curr HIV Res. 2019;17(6):388-396. doi: 10.2174/1570162X17666191106112018. Curr HIV Res. 2019. PMID: 31702526 Review.
Cited by
-
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.J Exp Med. 2013 Mar 11;210(3):517-34. doi: 10.1084/jem.20120572. Epub 2013 Mar 4. J Exp Med. 2013. PMID: 23460728 Free PMC article.
-
Frequency of coreceptor tropism in PBMC samples from HIV-1 recently infected blood donors by massively parallel sequencing: the REDS II study.Virol J. 2015 May 14;12:74. doi: 10.1186/s12985-015-0307-3. Virol J. 2015. PMID: 25966986 Free PMC article.
-
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.PLoS Pathog. 2006 Jul;2(7):e70. doi: 10.1371/journal.ppat.0020070. PLoS Pathog. 2006. PMID: 16839201 Free PMC article.
-
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.J Biol Chem. 2010 Jan 15;285(3):1681-91. doi: 10.1074/jbc.M109.049957. Epub 2009 Nov 16. J Biol Chem. 2010. PMID: 19917610 Free PMC article.
-
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition.Antimicrob Agents Chemother. 2008 Jul;52(7):2608-15. doi: 10.1128/AAC.01226-07. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443125 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials